NCT07386704 2026-02-04
Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer
Peking University First Hospital
Phase 2 Enrolling by invitation
Clinical Trials
5 trialsNCT07346248 2026-01-16
POCAT
Istituto Clinico Humanitas
Enrolling by invitation
NCT06997913 2025-05-31
AICRC
The First Affiliated Hospital of Air Force Medicial University
Enrolling by invitation
NCT06429995 2024-05-28
SFPMAMMA
University Medical Center Groningen
Enrolling by invitation
NCT06048926 2023-09-21
Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase NA Enrolling by invitation